Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Altman Z-score

Bristol-Myers Squibb Company Altman Z-score Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Altman Z-score from 2010 to 2020.
  • Bristol-Myers Squibb Company Altman Z-score for the quarter ending September 09, 2020 was 2.13 a 19.04% increase of 0.40 year over year
  • Bristol-Myers Squibb Company Altman Z-score for the last 12 months ending September 09, 2020 was 2.06 a 26.13% increase of 0.54 year over year
  • Bristol-Myers Squibb Company Annual Altman Z-score for 2019 was 1.52 a -266.55% decrease of -4.05 from 2018
  • Bristol-Myers Squibb Company Annual Altman Z-score for 2018 was 5.57 a 8.03% increase of 0.45 from 2017
  • Bristol-Myers Squibb Company Annual Altman Z-score for 2017 was 5.12 a -22.91% decrease of -1.17 from 2016
Other Balance Sheet Metrics:
  • Bristol-Myers Squibb Company Total Assets for the quarter ending September 09, 2018 was $33,734m a 0.54% increase of 183m year over year
  • Bristol-Myers Squibb Company Other Liabilities for the quarter ending September 09, 2018 was $4,603m a -12.23% decrease of -563m year over year
  • Bristol-Myers Squibb Company Total Equity for the quarter ending December 12, 2018 was $13,750m a 6.14% increase of 844m year over year
View Chart On Koyfin

Quarterly BMY Altman Z-score Data

09/20202.13
06/20202.00
03/20202.10
12/20191.72
09/20193.51
06/20193.64
03/20195.55
12/20185.37
09/20185.83
06/20185.52

Annual BMY Altman Z-score Data

20191.52
20185.57
20175.12
20166.30
20156.13
20145.14
20133.92
20123.73
20114.75
20104.68